Lista de obras - Nicholas Erho - Dominio Público Uruguay

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth

artículo científico publicado en 2016

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

artículo científico

Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

artículo científico publicado en 2015

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens

artículo científico publicado en 2016

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

artículo científico publicado en 2016

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

artículo científico publicado en 2017

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

artículo científico publicado en 2015

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.

artículo científico publicado en 2014

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

artículo científico publicado en 2017

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

artículo científico publicado en 2018

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

artículo científico publicado en 2016

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

artículo científico publicado en 2013

Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer

artículo científico publicado en 2014

Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality

artículo científico publicado en 2017

Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer

artículo científico publicado en 2015

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

artículo científico publicado en 2017

Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

artículo científico publicado en 2012

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.

artículo científico publicado en 2016

Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer

artículo científico publicado en 2015

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

artículo científico publicado en 2017

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

artículo científico publicado en 2016

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

artículo científico publicado en 2017

Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer

artículo científico publicado en 2013

Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer

artículo científico publicado en 2016

Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer

artículo científico publicado en 2016

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies

artículo científico publicado en 2015

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report

artículo científico publicado en 2016

Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.

artículo científico publicado en 2016

Prostate cancer radiomics and the promise of radiogenomics

artículo científico publicado en 2016

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

artículo científico publicado en 2014

Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

artículo científico publicado en 2015

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

artículo científico publicado en 2016

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome

artículo científico publicado en 2012

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

artículo científico publicado en 2017

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

artículo científico publicado en 2018

The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

artículo científico publicado en 2015

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

artículo científico publicado en 2013

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

artículo científico publicado en 2018

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

artículo científico publicado en 2014

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance

artículo científico publicado en 2017

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

artículo científico publicado en 2015

Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.

artículo científico publicado en 2017

Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes

artículo científico publicado en 2017

Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer

artículo científico publicado en 2012

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

artículo científico publicado en 2014

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features

artículo científico publicado en 2017

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

artículo científico publicado en 2013

Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis

artículo científico publicado en 2013

Lista de obras de Nicholas Erho

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer

Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality

Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma

Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.

Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer

Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer

Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report

Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.

Prostate cancer radiomics and the promise of radiogenomics

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome

TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer

The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.

The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer

Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.

Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes

Transcriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancer

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

Whole-transcriptome profiling of thyroid nodules identifies expression-based signatures for accurate thyroid cancer diagnosis